**3. Conclusions**

The present chapter narrates the distinct pharmacological actions of benzimidazole integrated quinoline hybrid scaffolds. The prime objective of this study is to investigate the pharmacological potential of hybrid compounds consisting of benzimidazole and quinoline moieties in a single molecule. This can help improve their potential to interact with a wide range of biological targets and enhance their pharmacological properties. The efforts are rationalised to develop such scaffolds that could impart numerous pharmacological effects to accomplish the desired aim. Further, the structure–activity relationship, pharmacokinetic, pharmacodynamic, and toxicological studies of benzimidazole-quinoline hybrid derivatives will be highly beneficial for designing and developing novel bioactive agents in the future.
